UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

Therapeutic Advances in Medical Oncology, 2019, Vol.11, p.1758835919894105-1758835919894105

2019

Link zum Volltext

Verfügbarkeit prüfen

Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis

Annals of surgical oncology, 2022-01, Vol.29 (1), p.427-436

2022

Link zum Volltext

Verfügbarkeit prüfen

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

Journal of clinical oncology, 2008-01, Vol.26 (1), p.44-53

2008

Link zum Volltext

Verfügbarkeit prüfen

Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated

Breast cancer research and treatment, 2021-07, Vol.188 (2), p.511-524

2021

Link zum Volltext

Verfügbarkeit prüfen

ASO Visual Abstract: Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: is it Oncologically Safe? A Retrospective Matched-Cohort Analysis

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.764-765

2021

Link zum Volltext

Verfügbarkeit prüfen

A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer

Clinical cancer research, 2005-07, Vol.11 (13), p.4741-4748

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy

Breast (Edinburgh), 2020-10, Vol.53, p.138-142

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

Breast cancer research and treatment, 2010-12, Vol.124 (3), p.689-699

2010

Link zum Volltext

Verfügbarkeit prüfen

Low-risk triple-negative breast cancers: Clinico-pathological and molecular features

Critical reviews in oncology/hematology, 2022-04, Vol.172, p.103643-103643, Article 103643

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

European journal of surgical oncology, 2021-04, Vol.47 (4), p.804-812

2021

Link zum Volltext

Verfügbarkeit prüfen

Metronomic therapy and breast cancer: A systematic review

Cancer treatment reviews, 2014-09, Vol.40 (8), p.942-950

2014

Link zum Volltext

Verfügbarkeit prüfen

Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after treatment with endocrine therapy and CDK 4/6 inhibitors within randomized clinical trials

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1059-1059

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: a phase II trial

Cancer letters, 2017-08, Vol.400, p.276-281

2017

Link zum Volltext

Verfügbarkeit prüfen

A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements

Tumori, 2023-04, Vol.109 (2), p.197-202

2023

Link zum Volltext

Verfügbarkeit prüfen

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

Breast (Edinburgh), 2017-08, Vol.34, p.83-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Metaplastic breast cancer: Prognostic and therapeutic considerations

Journal of surgical oncology, 2021-01, Vol.123 (1), p.61-70

2021

Link zum Volltext

Verfügbarkeit prüfen

The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: Ready for prime time?

Cancer treatment reviews, 2013-12, Vol.39 (8), p.886-890

2013

Link zum Volltext

Verfügbarkeit prüfen

Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

Breast cancer research and treatment, 2009-07, Vol.116 (2), p.317-328

2009

Link zum Volltext

Verfügbarkeit prüfen

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Science translational medicine, 2023-04, Vol.15 (693), p.eadf1147

2023

Link zum Volltext

Verfügbarkeit prüfen

Invasive lobular breast cancer: subtypes and outcome

Breast cancer research and treatment, 2012-06, Vol.133 (2), p.713-723

2012

Link zum Volltext

Verfügbarkeit prüfen

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy

Annals of oncology, 2015-02, Vol.26 (2), p.307-313

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of breast cancer in young women: do we need more aggressive therapies?

Journal of thoracic disease, 2013-06, Vol.5 Suppl 1 (Suppl 1), p.S47-S54

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(66)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Oncology
(44)
Humans
(40)
Female
(34)
Breast Cancer
(30)
Middle Aged
(26)
Adult
(21)
Breast Neoplasms - Drug Therapy
(18)
Breast Neoplasms - Pathology
(17)
Aged
(15)
Disease-Free Survival
(15)
Prognosis
(15)
Chemotherapy
(13)
Biological And Medical Sciences
(12)
Hematology, Oncology And Palliative Medicine
(12)
Medical Sciences
(12)
Tumors
(12)
Cancer Therapies
(11)
Medicine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated

ASO Visual Abstract: Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: is it Oncologically Safe? A Retrospective Matched-Cohort Analysis

A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

Pegylated Liposomal Doxorubicin (Caelyx ® ) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors

Low-risk triple-negative breast cancers: Clinico-pathological and molecular features

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

Metronomic therapy and breast cancer: A systematic review

Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after treatment with endocrine therapy and CDK 4/6 inhibitors within randomized clinical trials

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: a phase II trial

A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

Metaplastic breast cancer: Prognostic and therapeutic considerations

The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: Ready for prime time?

Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Invasive lobular breast cancer: subtypes and outcome

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy

Treatment of breast cancer in young women: do we need more aggressive therapies?

Suchergebnisse filtern